Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption

Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption

Abstract INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ribeiro, Ághata Cardoso da Silva, Crozatti, Márcia Terezinha Lonardoni, Silva, Adilson Aderito da, Macedo, Rodrigo Spineli, Machado, Antonia Maria de Oliveira, Silva, Antonio Távora de Albuquerque
Format: Dataset
Sprache:eng
Schlagworte:
Medicine
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Ribeiro, Ághata Cardoso da Silva
Crozatti, Márcia Terezinha Lonardoni
Silva, Adilson Aderito da
Macedo, Rodrigo Spineli
Machado, Antonia Maria de Oliveira
Silva, Antonio Távora de Albuquerque
description Abstract INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. CONCLUSIONS: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.
doi_str_mv 10.6084/m9.figshare.11452968
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_11452968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_11452968</sourcerecordid><originalsourceid>FETCH-LOGICAL-d918-e4a10ad123101a88cf6371afa9a931cd32655f6e9f9becdde2898649e28908043</originalsourceid><addsrcrecordid>eNo1j8tOAyEYhdm4MNU3cMEDOCPMBcGdmXhp0qQu6hr_wk9LMkADMya-vdNoFyfn5Fuc5CPkjrNaMNk9BFU7fyhHyFhz3vWNEvKafH0UnG0KKUKhgHk--JgKUB_pdES6Hj6f6CnjN4wYDd7TjMWXCZa94OT8uDCIdsnkgzc57T2M1KRY5nCafIo35MrBWPD2v1dk9_qyG96rzfZtPTxvKqu4rLADzsDypuWMg5TGifaRgwMFquXGto3oeydQObVHYy02UknRqXMzybp2Rbq_WwsTGD-hPmUfIP9ozvTZXwelL_764t_-ArbAWIw</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption</title><source>DataCite</source><creator>Ribeiro, Ághata Cardoso da Silva ; Crozatti, Márcia Terezinha Lonardoni ; Silva, Adilson Aderito da ; Macedo, Rodrigo Spineli ; Machado, Antonia Maria de Oliveira ; Silva, Antonio Távora de Albuquerque</creator><creatorcontrib>Ribeiro, Ághata Cardoso da Silva ; Crozatti, Márcia Terezinha Lonardoni ; Silva, Adilson Aderito da ; Macedo, Rodrigo Spineli ; Machado, Antonia Maria de Oliveira ; Silva, Antonio Távora de Albuquerque</creatorcontrib><description>Abstract INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. CONCLUSIONS: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.</description><identifier>DOI: 10.6084/m9.figshare.11452968</identifier><language>eng</language><publisher>SciELO journals</publisher><subject>Medicine</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.11452968$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ribeiro, Ághata Cardoso da Silva</creatorcontrib><creatorcontrib>Crozatti, Márcia Terezinha Lonardoni</creatorcontrib><creatorcontrib>Silva, Adilson Aderito da</creatorcontrib><creatorcontrib>Macedo, Rodrigo Spineli</creatorcontrib><creatorcontrib>Machado, Antonia Maria de Oliveira</creatorcontrib><creatorcontrib>Silva, Antonio Távora de Albuquerque</creatorcontrib><title>Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption</title><description>Abstract INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. CONCLUSIONS: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.</description><subject>Medicine</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2019</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1j8tOAyEYhdm4MNU3cMEDOCPMBcGdmXhp0qQu6hr_wk9LMkADMya-vdNoFyfn5Fuc5CPkjrNaMNk9BFU7fyhHyFhz3vWNEvKafH0UnG0KKUKhgHk--JgKUB_pdES6Hj6f6CnjN4wYDd7TjMWXCZa94OT8uDCIdsnkgzc57T2M1KRY5nCafIo35MrBWPD2v1dk9_qyG96rzfZtPTxvKqu4rLADzsDypuWMg5TGifaRgwMFquXGto3oeydQObVHYy02UknRqXMzybp2Rbq_WwsTGD-hPmUfIP9ozvTZXwelL_764t_-ArbAWIw</recordid><startdate>20191225</startdate><enddate>20191225</enddate><creator>Ribeiro, Ághata Cardoso da Silva</creator><creator>Crozatti, Márcia Terezinha Lonardoni</creator><creator>Silva, Adilson Aderito da</creator><creator>Macedo, Rodrigo Spineli</creator><creator>Machado, Antonia Maria de Oliveira</creator><creator>Silva, Antonio Távora de Albuquerque</creator><general>SciELO journals</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20191225</creationdate><title>Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption</title><author>Ribeiro, Ághata Cardoso da Silva ; Crozatti, Márcia Terezinha Lonardoni ; Silva, Adilson Aderito da ; Macedo, Rodrigo Spineli ; Machado, Antonia Maria de Oliveira ; Silva, Antonio Távora de Albuquerque</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d918-e4a10ad123101a88cf6371afa9a931cd32655f6e9f9becdde2898649e28908043</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Medicine</topic><toplevel>online_resources</toplevel><creatorcontrib>Ribeiro, Ághata Cardoso da Silva</creatorcontrib><creatorcontrib>Crozatti, Márcia Terezinha Lonardoni</creatorcontrib><creatorcontrib>Silva, Adilson Aderito da</creatorcontrib><creatorcontrib>Macedo, Rodrigo Spineli</creatorcontrib><creatorcontrib>Machado, Antonia Maria de Oliveira</creatorcontrib><creatorcontrib>Silva, Antonio Távora de Albuquerque</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ribeiro, Ághata Cardoso da Silva</au><au>Crozatti, Márcia Terezinha Lonardoni</au><au>Silva, Adilson Aderito da</au><au>Macedo, Rodrigo Spineli</au><au>Machado, Antonia Maria de Oliveira</au><au>Silva, Antonio Távora de Albuquerque</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption</title><date>2019-12-25</date><risdate>2019</risdate><abstract>Abstract INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. CONCLUSIONS: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.</abstract><pub>SciELO journals</pub><doi>10.6084/m9.figshare.11452968</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.11452968
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_11452968
source DataCite
subjects Medicine
title Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T03%3A37%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Ribeiro,%20%C3%81ghata%20Cardoso%20da%20Silva&rft.date=2019-12-25&rft_id=info:doi/10.6084/m9.figshare.11452968&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_11452968%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true